1993
DOI: 10.1016/s0022-5223(19)34237-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of 2,3-butanedione monoxime in isolated hearts: Protection during reperfusion after global ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…Second, we used the excitation-contraction uncoupler BDM in this study. On one hand, BDM is known to have an antifibrillatory effect (27,35), and the protective effect of BDM from ischemia-reperfusion injury is also well known (2,4,45). These effects of BDM could bias our estimates of vulnerable window toward smaller degree.…”
Section: Discussionmentioning
confidence: 99%
“…Second, we used the excitation-contraction uncoupler BDM in this study. On one hand, BDM is known to have an antifibrillatory effect (27,35), and the protective effect of BDM from ischemia-reperfusion injury is also well known (2,4,45). These effects of BDM could bias our estimates of vulnerable window toward smaller degree.…”
Section: Discussionmentioning
confidence: 99%
“…The heart was reperfused in the MR scanner using an oxygenated Krebs‐Henseleit bicarbonate buffer (pH 7.4, temperature 38°C), mixed with heparinized blood (4:1 proportion). 2,3 Butanedione monoxime (BDM 97%; Aldrich, Paris, France), a potent reversible inhibitor of the actin‐myosin interaction, was added at a concentration of 30 mmol/l to the perfusate to inhibit motion artifacts related to contraction and to favor the homogeneity of myocardial perfusion through its vasodilation and protective effects on microvascularization (25).…”
Section: Methodsmentioning
confidence: 99%
“…For example, BDM shortens the APD in sheep and guinea pig, 9 but prolongs the APD in the mouse 10 . BDM has also been shown to enhance shock‐induced arrhythmias, 11 and to provide a protective effect during reperfusion after ischemia 12 . As a result of these side effects, and in particular the effects directly related to ischemia, BDM may not be suitable as a motion blocker for ischemia studies.…”
Section: Introductionmentioning
confidence: 99%